Key points are not available for this paper at this time.
Evaluation of the DNA-PK inhibitors plus TOP2 poisons in preclinical models of EWS
Collins et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: